AMSTERDAM, March 13 (Reuters) – Dutch biotech firm Pharming PHAR.AS said on Monday it expected to have full access to its cash on deposit at Silicon Valley Bank, following the U.S. government’s move to insure all depositors at the collapsed lender.
Pharming on Sunday said it held $45 million in Silicon Valley Bank’s SIVB.O U.S. and British units.
(Reporting by Bart Meijer; editing by Jason Neely)
((Bart.Meijer@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
